Eksigent Announces Major Expansion for HPLC Manufacturing and Service

Eksigent Technologies announce that it will increase manufacturing capacity by 40 percent to meet strong demand for its HPLC products. “The need for this increase in product build capability is being driven by higher than expected customer demand for both our cHiPLC®- nanoflex for proteomics, introduced in February of this year, and our ExpressHT™-Ultra HPLC System for ADME-Tox and DMPK studies, introduced last fall,” stated David Neyer, vice president and cofounder of Eksigent. “We are also actively recruiting for field service personnel to ensure that customer installations are maintained at our traditionally short lead times.”

The new cHiPLC-nanoflex System is a docking station for up to three microfluidic chips that contain nanoLC or trap columns. The system delivers improved reproducibility and ease of use to proteomics research. The expressHT-Ultra HPLC system is the latest offering in Eksigent’s line of products for small molecule analysis. It provides short cycle times and high throughput for LC/MS studies of pharmacokinetics and drug metabolism.